← Leaderboards
Susan Leilani Fink
Yale University
$4,922,371
Attributed
$4,922,371
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $808K · FY2015–25$1M$750K$500K$250K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,922,371 · 6
By mechanism
R01$2,221,620 · 1
R21$1,779,067 · 4
K08$921,684 · 1
Top collaborators
No co-investigators on record.
Most similar at Yale University
Same institution · by research overlap
- Mark J Shlomchik$51,286,869
- Richard A Flavell$31,785,615
- Carlos Fernandez Hernando$14,750,691
- James F Leckman$15,657,804
- Jack A Elias$29,308,180
Others in their field
Top investigators on “Molecular”
- David Heimbrook · Leidos Biomedical Research, Inc.$871,088,761
- Leonard Freedman · Leidos Biomedical Research, Inc.$468,573,385
- Richard Webby · St. Jude Children'S Research Hospital$254,843,170
- Larry Arthur$238,531,074
- Gregory H Reaman · National Childhood Cancer Foundation$230,630,913
- Ralph Parchment · Leidos Biomedical Research, Inc.$193,231,914
Research focus
MolecularExperimental StudyProteinsVirus ReplicationCellsPharmaceutical PreparationsIn VivoViralResponsePathway InteractionsTherapeutic TargetMediatingAffectFutureMedicalHuman DiseaseGeneticEndoplasmic ReticulumInfectionInsightInflammatoryBasePre-ClinicalCell Type
Grant awards (18)
Role of IRE1 Alpha in Coronavirus Infections$557,476
R01 · FY2025 · AI · contact PI
Role of IRE1 Alpha in Coronavirus Infections$574,718
R01 · FY2024 · AI · contact PI
Mechanism of Muscimol as a Novel Pyroptosis Inhibitor$233,250
R21 · FY2024 · AI · contact PI
Role of IRE1 Alpha in Coronavirus Infections$544,713
R01 · FY2023 · AI · contact PI
Mechanism of Muscimol as a Novel Pyroptosis Inhibitor$194,375
R21 · FY2023 · AI · contact PI
Role of IRE1 Alpha in Coronavirus Infections$544,713
R01 · FY2022 · AI · contact PI
Neurosteroid Inhibition of Pyroptotic Lysis$233,250
R21 · FY2021 · AI · contact PI
Neurosteroid Inhibition of Pyroptotic Lysis$194,375
R21 · FY2020 · AI · contact PI
Role of IRE1 Alpha in Zika Virus Infection$233,250
R21 · FY2019 · AI · contact PI
Role of Ire1alpha in Resistance to Viral-Induced Apoptosis$187,312
K08 · FY2019 · AI · contact PI
Role of IRE1 Alpha in Zika Virus Infection$69,244
R21 · FY2019 · AI · contact PI
Targeting Zika Virus Infection with Chloroquine and Related Drugs$194,375
R21 · FY2018 · AI · contact PI
Role of IRE1 Alpha in Zika Virus Infection$194,323
R21 · FY2018 · AI · contact PI
Role of Ire1alpha in Resistance to Viral-Induced Apoptosis$187,312
K08 · FY2018 · AI · contact PI
Targeting Zika Virus Infection with Chloroquine and Related Drugs$232,625
R21 · FY2017 · AI · contact PI
Role of Ire1alpha in Resistance to Viral-Induced Apoptosis$187,312
K08 · FY2017 · AI · contact PI
Role of Ire1alpha in Resistance to Viral-Induced Apoptosis$179,874
K08 · FY2016 · AI · contact PI
Role of Ire1alpha in Resistance to Viral-Induced Apoptosis$179,874
K08 · FY2015 · AI · contact PI